Professor Paul De Souza

Co-Founder, Director (Non-Executive)

BSC(Med), MBBS, MPH, PhD, FRACP

Paul is a practicing medical oncologist with a strong interest in clinical research. From his first research posting at the University of Virginia, to his time as a Clinical Research Physician with Eli Lilly Australia, to his appointment as the Professor of Medical Oncology at Western Sydney University, and now Professor of Medicine at the University of Sydney at Nepean Cancer Centre, Paul’s focus has been on bridging the preclinical and clinical aspects of drug development and how that process can be expedited in order to bring much-needed breakthrough treatments to the estimated 10 million global deaths each from cancer.

Paul is co-developer of the Company’s ALPHA technology platform.